|
|
||||||||||
|
J Am Coll Cardiol, 1990; 16:553-562 © 1990 by the American College of Cardiology Foundation |
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
The relative influences of revascularization status and baseline characteristics on long-term outcome were examined in 867 patients with multivessel coronary disease who had undergone successful coronary angioplasty. These patients represented 83% of a total of 1,039 patients in whom angioplasty had been attempted with an in-hospital mortality and infarction rate of 2.5% and 4.8%, respectively. Emergency coronary bypass surgery was needed in 4.9%. Of the 867 patients, 41% (group 1) were considered to have complete revascularization and 59% (group 2) to have incomplete revascularization. Univariate analysis revealed major differences between these two groups with patients in group 2 characterized by advanced age, more severe angina, a greater likelihood of previous coronary surgery and infarction, more extensive disease and poorer left ventricular function. Over a mean follow-up period of 26 months, the probability of event-free survival was significantly lower for group 2 only with respect to the need for coronary artery surgery (p = 0.004) and occurrence of severe angina (p = 0.04). The difference in mortality was of borderline significance (p = 0.051) and there were no significant differences between groups 1 and 2 in either the incidence of myocardial infarction or the need for repeat angioplasty. Multivariate analysis identified independent baseline predictors of late cardiac events that were then used to adjust the probabilities of event-free survival. This adjustment effectively removed any significant influence of completeness of revascularization on event-free survival for any of the above end points including the combination of death, myocardial infarction and need for coronary artery surgery. Therefore, late outcome in these patients is not significantly influenced by revascularization status but depends more on baseline patient characteristics.
This article has been cited by other articles:
![]() |
E. L. Hannan, M. Racz, D. R. Holmes, S. B. King III, G. Walford, J. A. Ambrose, S. Sharma, S. Katz, L. T. Clark, and R. H. Jones Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era Circulation, May 23, 2006; 113(20): 2406 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Rodriguez, J. Baldi, C. F. Pereira, J. Navia, M. R. Alemparte, A. Delacasa, F. Vigo, D. Vogel, W. O'Neill, I. F. Palacios, et al. Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II) J. Am. Coll. Cardiol., August 16, 2005; 46(4): 582 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. B. M. van den Brand, B. J. W. M. Rensing, M.-a. M. Morel, D. P. Foley, V. de Valk, A. Breeman, H. Suryapranata, M. M. P. Haalebos, W. Wijns, F. Wellens, et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial J. Am. Coll. Cardiol., February 20, 2002; 39(4): 559 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kilo, H. Baumer, M. Czerny, M. J. Hiesmayr, M. Ploner, E. Wolner, and M. Grimm Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients Ann. Thorac. Surg., February 1, 2001; 71(2): 537 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Whitlow, A. P. Dimas, T. M. Bashore, R. M. Califf, M. G. Bourassa, B. R. Chaitman, A. D. Rosen, K. E. Kip, M. L. Stadius, E. L. Alderman, et al. Relationship of extent of revascularization with angina at one year in the bypass angioplasty revascularization investigation (BARI) J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1750 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Kip, M. G. Bourassa, A. K. Jacobs, L. Schwartz, F. Feit, E. L. Alderman, B. H. Weiner, M. B. Weiss, M. A. Kellett Jr, B. L. Sharaf, et al. Influence of Pre-PTCA Strategy and Initial PTCA Result in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI) Circulation, August 31, 1999; 100(9): 910 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Bourassa, K. E. Kip, A. K. Jacobs, R. H. Jones, G. Sopko, A. D. Rosen, B. L. Sharaf, L. Schwartz, B. R. Chaitman, E. L. Alderman, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?: The bypass angioplasty revascularization investigation (BARI) J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1627 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kornowski, R. Mehran, L. F. Satler, A. D. Pichard, K. M. Kent, A. Greenberg, G. S. Mintz, M. K. Hong, and M. B. Leon Procedural results and late clinical outcomes following multivessel coronary stenting J. Am. Coll. Cardiol., February 1, 1999; 33(2): 420 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, A. Lerman, D. E. Grill, C. S. Rihal, and D. R. Holmes Jr. Medical Therapy after Successful Percutaneous Coronary Revascularization Ann Intern Med, January 19, 1999; 130(2): 108 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aristides, M. Gliksman, N. Rajan, and P. Davey Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients Heart, January 1, 1998; 79(1): 12 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hasdai, K. N. Garratt, D. E. Grill, A. Lerman, and D. R. Holmes Effect of Smoking Status on the Long-Term Outcome after Successful Percutaneous Coronary Revascularization N. Engl. J. Med., March 13, 1997; 336(11): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhao, B. G. Brown, D. K. Stewart, L. A. Hillger, H. X. Barnhart, A. S. Kosinski, W. S. Weintraub, and S. B. King III Effectiveness of Revascularization in the Emory Angioplasty Versus Surgery Trial : A Randomized Comparison of Coronary Angioplasty With Bypass Surgery Circulation, June 1, 1996; 93(11): 1954 - 1962. [Abstract] [Full Text] |
||||
![]() |
N. Wang, S. R. Gundry, G. Van Arsdell, A. J. Razzouk, A. C. Hill, M. Sjolander, K. A. Cavazos, J. M. Brewer, E. E. Vyhmeister, and L. L. Bailey Percurtaneous transluminal coronary angioplasty failures in patients with multivessel diseaseIs there an increased risk? J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 214 - 223. [Abstract] [Full Text] |
||||
![]() |
C. W. Hamm, J. Reimers, T. Ischinger, H.-J. Rupprecht, J. Berger, W. Bleifeld, and The German Angioplasty Bypass Surgery Investigatio A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease N. Engl. J. Med., October 20, 1994; 331(16): 1037 - 1043. [Abstract] [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |